Muscular Dystrophy Treatment Market Growth Accelerated by New Approvals and Launches


 Muscular Dystrophy refers to a group of genetic diseases that weaken the body's muscles over time. The diseases range in severity and include Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy, Limb-girdle Muscular Dystrophy and others. Treatments focus on disease management through physical therapy, orthopedic bracing and medication. There are limited FDA-approved treatment options available for Muscular Dystrophy patients currently. However, new drug developments are accelerating approvals and market growth.

The global Muscular Dystrophy Treatment Market is estimated to be valued at US$ 2.30 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
In recent years, the Muscular Dystrophy Treatment market saw significant growth driven by new drug approvals and commercial launches. In 2023, the FDA approved Amondys 45 (casimersen) by Sarepta Therapeutics for treating DMD patients amenable to skipping exon 45. This is the second disease-

modifying treatment approved after Exondys 51 for DMD. Several pharmaceutical companies are actively conducting clinical trials and developing drug candidates targeting different types of Muscular Dystrophy. This extensive pipeline is expected to receive regulatory approvals over the forecast period, driving higher treatment uptake and market revenue growth for Muscular Dystrophy Treatment.

Segment Analysis
Muscular Dystrophy Treatment Market is segmented by Therapy Type into Gene Therapy, Stem Cell Therapy and Small Molecules & Biologicals. Stem cell therapy dominates the market currently as it holds promise for regenerating damaged muscle cells and tissues. Several clinical trials are underway to test the efficacy and safety of stem cell therapy for different types of muscular dystrophy.

Key Takeaways
The global Muscular Dystrophy Treatment market is expected to witness high growth. Regional analysis related content comprises The North America region currently dominates the global market due to presence of major players and advanced healthcare infrastructure. Asia Pacific region is expected to grow at fastest CAGR during the forecast period owing to rising healthcare spending and increasing patient population.

Key players operating in the Muscular Dystrophy Treatment market are F. Hoffmann-La Roche AG, Pfizer Inc., PTC Therapeutics, Sarepta Therapeutics and Solid Biosciences.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more